- Press releasesPress releases
- Events & ActivityEvents & Activity
- Dicerna Announces Pricing of Follow-On Public Offering of Common Stock
- Dicerna Announces Proposed Public Offering of Common Stock
- Dicerna Announces First Human Dosed in Phase 1 Clinical Trial of DCR-PHXC for Treatment of All Forms of Primary Hyperoxaluria
- Dicerna to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
- Dicerna to Present at the Stifel 2017 Healthcare Conference
- Dicerna Reports Third Quarter 2017 Financial and Operating Results and Provides Corporate Update
- Dicerna to Report Third Quarter 2017 Financial Results and Host Conference Call on November 2, 2017
Dicerna Pharmaceuticals Inc (DRNA:NSQ) closed at 9.34, -8.84% below its 52-week high of 10.24, set on Nov 20, 2017.
2.42Feb 03 201710.24Nov 20 2017
Markit short selling activity
|Market cap||482.08m USD|
|EPS (TTM)||-3.43 |
Data delayed at least 15 minutes, as of Jan 17 2018 21:00 GMT.